Microscopic residual disease is a risk factor in the primary treatment of breast cancer

Strahlentherapie und Onkologie

Volumn 178, Issue 6, 2002, Pages 307-313

  Schuck, Andreas ^a   Könemann, Stefan ^a   Heinen, Karin ^a   Rübe, Claudia E ^b   Hesselmann, Stefan ^a   Reinartz, Gabriele ^a   Schüller, Patrick ^a   Micke, Oliver ^a   Schäfer, Ulrich ^a   Willich, Normann ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Breast cancer; Electron boost; Local control; Postoperative radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; RECURRENCE RISK; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MASTECTOMY, SIMPLE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0036286278     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-0950-7     Document Type: Article

References (40)

1. Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trials
2. The impact of tumor size and histology on local control after breast conserving surgery
3. Multiple significance testing and ist relevance for interpretation of results. Audit of the journal "Strahlentherapie und Onkologie"
4. Risk factors in breast-conservation therapy
5. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer: An update
6. Analysis of loco-regional relapse in patients with early breast cancer treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy
7. Impact of a boost dose of 15 Gy on local control in patients with early breast cancer: The EORTC "Boost versus no Boost" trial
8. Konturdefekte bei brusterhaltender Therapie des Mammakarzinoms
9. Actuarial analysis of time failure data and its relevance for interpretation of results
10. Influence of the timing of surgery and postoperative radiotherapy on treatment results
11. Reanalysis and results after 12 years of follow-up in a randomized trial comparing total mastectoy with lumpectomy with or without irradiation in the treatment of breast cancer
12. Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of Scottish trial
13. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
14. Breast conserving therapy for early stage invasive cancer
15. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy
16. Intraoperative strahlentherapie (IORT) in der behandlung des mammakarzinoms - Eine neue therapeutische alternative im rahmen der brusterhaltenden therapie?
17. Breast conserving therapy, a boost dose of radiotherapy is not necessary when negative margins of excision are achieved
18. Variation in supraclavicular lymph node depth is partly determined by treatment position
19. Which patients don't need a tumor-bed boost after whole breast radiotherapy?
20. The importance of local control in the conservative treatment of breast cancer
21. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial
22. IORT for early breast cancer: A report on long-term results
23. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
24. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
25. CT-image based conformal brachytherapy of breast cancer. The significance of semi-3-D and 3-D treatment planning
26. Mammakarzinom der frau
27. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer
28. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France
29. Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma
30. Treatment planning of tangential breast irradiation using a simulator with CT-option compared to a conventional CT
31. Einfluß der lokalen kontrolle auf das gesamtüberleben nach brusterhaltender therapie des mammakarzinoms
32. Radiotherapie des mammakarzinoms
33. Strahlentherapie nach mastektomie - Interdisziplinäirer konsensus beendet kontroverse
34. Lebensalterspezifische ergebnisse der adjuvanten radiotherapie des mammakarzinoms
35. Sector resection with or without postoperative radiotherapy in stage I breast cancer. A randomized trial
36. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control
37. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials
38. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast
39. Breast conservation is a safe method in patients with small cancer of the breast. Long term results of 3 randomized trials on 1973 patients
40. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "Boost vs. no boost" trial